Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing precisely amoxicillin (as amoxicillin sodium) 500 milligram and clavulanic acid (as clavulanate potassium) 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely amoxicillin (as amoxicillin sodium) 500 milligram and clavulanic acid (as clavulanate potassium) 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Product containing precisely diamorphine hydrochloride 30 milligram/1 ampule powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely diamorphine hydrochloride 30 milligram/1 ampule powder for conventional release solution for injection (clinical drug) |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely cetrorelix (as cetrorelix acetate) 250 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely cetrorelix (as cetrorelix acetate) 250 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Diamorphine hydrochloride 100 mg powder for solution for injection ampule |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Diamorphine hydrochloride 100 mg powder for solution for injection ampule |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Cetrorelix (as cetrorelix acetate) 3 mg powder for solution for injection vial |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Cetrorelix (as cetrorelix acetate) 3 mg powder for solution for injection vial |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely diamorphine hydrochloride 500 milligram/1 ampule powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely diamorphine hydrochloride 500 milligram/1 ampule powder for conventional release solution for injection (clinical drug) |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Doxorubicin hydrochloride 10 mg powder for solution for injection vial |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Doxorubicin hydrochloride 10 mg powder for solution for injection vial |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely doxorubicin hydrochloride 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely doxorubicin hydrochloride 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
azithromycin 500 mg pulver til injektionsvæske, opløsning, hætteglas |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
azithromycin 500 mg pulver til injektionsvæske, opløsning, hætteglas |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
ceftazidim 1 g pulver til injektionsvæske, rekonstitution |
Has presentation strength numerator value |
False |
en |
Inferred relationship |
Some |
1 |
ceftazidim 1 g pulver til injektionsvæske, rekonstitution |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
ceftazidim 1 g pulver til injektionsvæske, rekonstitution |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Disodium pamidronate 90 mg powder for solution for injection vial |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Disodium pamidronate 90 mg powder for solution for injection vial |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely disodium pamidronate 15 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely disodium pamidronate 15 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Disodium pamidronate 30 mg powder for solution for injection vial |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Disodium pamidronate 30 mg powder for solution for injection vial |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
ceftazidim 250 mg pulver til injektionsvæske, opløsning, hætteglas |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
ceftazidim 250 mg pulver til injektionsvæske, opløsning, hætteglas |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
cyclophosphamid 1 g pulver til injektionsvæske, opløsning, hætteglas |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
cyclophosphamid 1 g pulver til injektionsvæske, opløsning, hætteglas |
Has presentation strength numerator value |
False |
en |
Inferred relationship |
Some |
1 |
cyclophosphamid 1 g pulver til injektionsvæske, opløsning, hætteglas |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely dacarbazine (as dacarbazine citrate) 200 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely dacarbazine (as dacarbazine citrate) 200 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Chloramphenicol (as chloramphenicol sodium succinate) 1 g powder for solution for injection vial |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Chloramphenicol (as chloramphenicol sodium succinate) 1 g powder for solution for injection vial |
Has presentation strength numerator value |
False |
en |
Inferred relationship |
Some |
1 |
Chloramphenicol (as chloramphenicol sodium succinate) 1 g powder for solution for injection vial |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Deferoxamine mesilate 2 g powder for solution for injection vial |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Deferoxamine mesilate 2 g powder for solution for injection vial |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely ampicillin (as ampicillin sodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely ampicillin (as ampicillin sodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Deferoxamine mesilate 500 mg powder for solution for injection vial |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Deferoxamine mesilate 500 mg powder for solution for injection vial |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely clarithromycin 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely clarithromycin 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
cyclophosphamid 200 mg pulver til infusionsvæske, opløsning, hætteglas |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
cyclophosphamid 200 mg pulver til infusionsvæske, opløsning, hætteglas |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely ampicillin (as ampicillin sodium) 250 milligram and flucloxacillin (as flucloxacillin sodium) 250 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Product containing precisely ampicillin (as ampicillin sodium) 250 milligram and flucloxacillin (as flucloxacillin sodium) 250 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
cyclophosphamid 500 mg pulver til injektionsvæske, opløsning, hætteglas |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
cyclophosphamid 500 mg pulver til injektionsvæske, opløsning, hætteglas |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Colistimethate sodium 500000 unit powder for solution for injection vial |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Colistimethate sodium 500000 unit powder for solution for injection vial |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Amifostine 500 mg powder for solution for injection vial |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Amifostine 500 mg powder for solution for injection vial |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely drotrecogin alfa 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely drotrecogin alfa 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely colistimethate sodium 1 million unit/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely colistimethate sodium 1 million unit/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength numerator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely colistimethate sodium 1 million unit/1 vial powder for conventional release solution for injection (clinical drug) |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
ceftazidim 500 mg pulver til injektionsvæske, rekonstitution |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
ceftazidim 500 mg pulver til injektionsvæske, rekonstitution |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely benzylpenicillin sodium 1.2 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely benzylpenicillin sodium 1.2 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Clarithromycin 250 mg granules for oral suspension sachet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Clarithromycin 250 mg granules for oral suspension sachet |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Amifostine 375 mg powder for solution for injection vial |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Amifostine 375 mg powder for solution for injection vial |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
ceftazidim 2 g pulver til injektionsvæske, rekonstitution |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
ceftazidim 2 g pulver til injektionsvæske, rekonstitution |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Botulinum toxin type A 500 unit powder for solution for injection vial |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Botulinum toxin type A 500 unit powder for solution for injection vial |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely calcium carbonate 2.5 gram/1 sachet granules for conventional release oral suspension (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely calcium carbonate 2.5 gram/1 sachet granules for conventional release oral suspension (clinical drug) |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Benzylpenicillin sodium 600 mg powder for solution for injection vial |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Benzylpenicillin sodium 600 mg powder for solution for injection vial |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Epirubicin hydrochloride 10 mg powder for solution for injection vial |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Epirubicin hydrochloride 10 mg powder for solution for injection vial |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Ceftriaxone (as ceftriaxone sodium) 250 mg powder for solution for injection vial |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Ceftriaxone (as ceftriaxone sodium) 250 mg powder for solution for injection vial |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Ceftriaxone (as ceftriaxone sodium) 1 g powder for solution for injection vial |
Has presentation strength numerator value |
False |
en |
Inferred relationship |
Some |
1 |
Ceftriaxone (as ceftriaxone sodium) 1 g powder for solution for injection vial |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Ceftriaxone (as ceftriaxone sodium) 1 g powder for solution for injection vial |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely ceftriaxone (as ceftriaxone sodium) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely ceftriaxone (as ceftriaxone sodium) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
azathioprin 50 mg pulver til injektionsvæske, opløsning, hætteglas |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
azathioprin 50 mg pulver til injektionsvæske, opløsning, hætteglas |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Capreomycin (as capreomycin sulfate) 1 g powder for solution for injection vial |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Capreomycin (as capreomycin sulfate) 1 g powder for solution for injection vial |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Capreomycin (as capreomycin sulfate) 1 g powder for solution for injection vial |
Has presentation strength numerator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely cefpirome (as cefpirome sulfate) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely cefpirome (as cefpirome sulfate) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely cefpirome (as cefpirome sulfate) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength numerator value |
False |
en |
Inferred relationship |
Some |
1 |
Amoxicillin (as amoxicillin sodium) 250 mg powder for solution for injection vial |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Amoxicillin (as amoxicillin sodium) 250 mg powder for solution for injection vial |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Agalsidase beta 35 mg powder for solution for injection vial |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Agalsidase beta 35 mg powder for solution for injection vial |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely cefpirome (as cefpirome sulfate) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely cefpirome (as cefpirome sulfate) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Amoxicillin (as amoxicillin sodium) 1 g powder for solution for injection vial |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Amoxicillin (as amoxicillin sodium) 1 g powder for solution for injection vial |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|